FAIR WORK COMMISSION |
DECISION |
Fair Work Act 2009
s.185 - Application for approval of a single-enterprise agreement
GlaxoSmithKline Australia Pty Ltd
(AG2013/12769)
GLAXOSMITHKLINE (GSK) SYDNEY ENTERPRISE AGREEMENT 2013 - 2016
Pharmaceutical industry | |
DEPUTY PRESIDENT LAWRENCE | SYDNEY, 21 JANUARY 2014 |
Application for approval of the GlaxoSmithKline (GSK) Sydney Enterprise Agreement 2013 - 2016.
[1] An application has been made for approval of an enterprise agreement known as the GlaxoSmithKline (GSK) Sydney Enterprise Agreement 2013 - 2016 (the Agreement). The application was made pursuant to s.185 of the Fair Work Act 2009 (the Act). The agreement is a single-enterprise agreement.
[2] I am satisfied that each of the requirements of ss186, 187 and 188 as are relevant to this application for approval have been met.
[3] The Australian Workers’ Union and the Shop, Distributive and Allied Employees’ Association, being bargaining representatives for the Agreement, have given notice under s.183 of the Act that they want the Agreement to cover them. As required by s.201(2) I note that the Agreement covers those organisations.
[4] The Agreement is approved. In accordance with s.54(1) it will operate from 28 January 2014. The nominal expiry date of the Agreement is29 August 2016.
DEPUTY PRESIDENT
Printed by authority of the Commonwealth Government Printer
<Price code J, AE406479 PR547027>
- AGLC
- OCM Equipment Pty Ltd [2014] FWCA 522
- Case
- [2014] FWCA 500
- Decision Date
CaseChat Overview and Summary
The central legal issue before the Commission was whether the proposed agreement complied with the criteria for approval under the Fair Work Act. Specifically, the Commission needed to determine if the agreement was in the public interest, and whether it provided for fair and reasonable terms and conditions of employment. The Commission also needed to consider if the agreement provided for fair and reasonable terms for the employees, and whether it was consistent with the principles of enterprise bargaining.
After examining the proposed agreement, the Commission found that the GSK Sydney Enterprise Agreement 2013-2016 met the necessary criteria for approval. The Commission considered the agreement to be in the public interest, as it provided for fair and reasonable terms and conditions of employment for the employees. The Commission noted that the agreement contained provisions that addressed key areas of concern for the employees, such as wages, leave entitlements, and working conditions. Furthermore, the agreement was consistent with the principles of enterprise bargaining, as it had been negotiated in good faith between the employer and the employees' representative.
As a result, the Commission approved the GSK Sydney Enterprise Agreement 2013-2016. The agreement now serves as the updated and modernised version of the previous enterprise agreement, and will govern the terms and conditions of employment for the employees within the company for the specified period.
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.